Drug Shortage Report for 20% PROSOL
Report ID | 132584 |
Drug Identification Number | 02141450 |
Brand name | 20% PROSOL |
Common or Proper name | Amino Acid Injection 20% w/v |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | VALINE LYSINE HISTIDINE ISOLEUCINE LEUCINE PHENYLALANINE THREONINE DL-METHIONINE TRYPTOPHAN ALANINE GLYCINE ARGININE PROLINE GLUTAMIC ACID SERINE L-ASPARTIC ACID TYROSINE |
Strength(s) | 1.44G 1.35G 1.18G 1.08G 1.08G 1G 0.98G 0.76G 0.32G 2.76G 2.06G 1.96G 1.34G 1.02G 1.02G 0.6G 0.05G |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 2L bag (4bags/case) (JB6186) |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2021-01-28 |
Actual start date | 2021-01-28 |
Estimated end date | 2021-03-01 |
Actual end date | 2021-03-01 |
Shortage status | Resolved |
Updated date | 2021-03-02 |
Company comments | Baxter Product Code JB6186. Product has been placed on allocation at 50% of historical usage. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-03-02 | English | Compare |
v5 | 2021-03-01 | French | Compare |
v4 | 2021-03-01 | English | Compare |
v3 | 2021-01-29 | English | Compare |
v2 | 2021-01-28 | French | Compare |
v1 | 2021-01-28 | English | Compare |
Showing 1 to 6 of 6